FilingReader Intelligence

Baiyunshan establishes 1.5bn yuan investment fund, gets debt approval

July 25, 2025 at 11:41 AM UTC•By FilingReader AI

Guangzhou Baiyunshan Pharmaceutical Holdings plans to invest 1.5 billion yuan into Guangzhou Guangyao Fund Phase II, representing 99.90% of its total capital.

Its subsidiary Guangzhou Pharmaceutical received approval to register 1.6 billion yuan in medium-term notes and 2 billion yuan in super short-term commercial papers, valid for two years.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Announcement by Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited regarding its participation in the investment and establishment of an equity investment fund and related party transactionJuly 25, 2025 at 08:00 AM UTC

Supplementary Source Documents

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announcement on the registration approval of its subsidiary's medium-term notes and ultra-short-term financing bondsJuly 25, 2025 at 08:00 AM UTC

Guangzhou Baiyunshan Pharmaceutical Holdings

SSE:600332•Shanghai Stock Exchange

RSS feed for Guangzhou Baiyunshan Pharmaceutical Holdings

News Alerts

Get instant email alerts when Guangzhou Baiyunshan Pharmaceutical Holdings publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →